Differential effects of alkaloids on memory in rodents
- PMID: 33972592
- PMCID: PMC8110766
- DOI: 10.1038/s41598-021-89245-w
Differential effects of alkaloids on memory in rodents
Abstract
Nicotinic acetylcholine receptors (nAChRs) play a critical role in the neuropharmacology of learning and memory. As such, naturally occurring alkaloids that regulate nAChR activity have gained interest for understanding and potentially improving memory function. In this study, we tested the acute effects of three known nicotinic alkaloids, nicotine, cotinine, and anatabine, in suppressing scopolamine-induced memory deficit in rodents by using two classic memory paradigms, Y-maze and novel object recognition (NOR) in mice and rats, respectively. We found that all compounds were able to suppress scopolamine-induced spatial memory deficit in the Y-maze spontaneous alternation paradigm. However, only nicotine was able to suppress the short-term object memory deficit in NOR, despite the higher doses of cotinine and anatabine used to account for their potential differences in nAChR activity. These results indicate that cotinine and anatabine can uniquely regulate short-term spatial memory, while nicotine seems to have more robust and general role in memory regulation in rodents. Thus, nAChR-activating alkaloids may possess distinct procognitive properties in rodents, depending on the memory types examined.
Conflict of interest statement
M.P., J.H., & K.K. are employed by Philip Morris International. P.C. and A.T. are employed by PBTLI and Medical College of Georgia, Augusta University. Philip Morris International employed PBTLI’s service for NOR experiment and Amylgen’s service for Y-maze experiment. This work was funded solely by Philip Morris International.
Figures



Similar articles
-
Differentiating the Neuropharmacological Properties of Nicotinic Acetylcholine Receptor-Activating Alkaloids.Front Pharmacol. 2022 Mar 22;13:668065. doi: 10.3389/fphar.2022.668065. eCollection 2022. Front Pharmacol. 2022. PMID: 35392565 Free PMC article.
-
Effects of nicotine on memory impairment induced by blockade of muscarinic, nicotinic and dopamine D2 receptors in rats.Eur J Pharmacol. 2003 Aug 8;474(2-3):227-32. doi: 10.1016/s0014-2999(03)02034-x. Eur J Pharmacol. 2003. PMID: 12921867
-
Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.Neuropsychopharmacology. 2003 Jul;28(7):1235-46. doi: 10.1038/sj.npp.1300150. Epub 2003 Apr 2. Neuropsychopharmacology. 2003. PMID: 12700710
-
Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish.Psychopharmacology (Berl). 2014 May;231(9):1975-85. doi: 10.1007/s00213-013-3340-1. Epub 2013 Dec 6. Psychopharmacology (Berl). 2014. PMID: 24311357
-
Cognitive improvements in a mouse model with substituted 1,2,3-triazole agonists for nicotinic acetylcholine receptors.ACS Chem Neurosci. 2015 Aug 19;6(8):1331-40. doi: 10.1021/acschemneuro.5b00059. Epub 2015 May 15. ACS Chem Neurosci. 2015. PMID: 25978789
Cited by
-
Lantana camara leaf extract ameliorates memory deficit and the neuroinflammation associated with scopolamine-induced Alzheimer's-like cognitive impairment in zebrafish and mice.Pharm Biol. 2023 Dec;61(1):825-838. doi: 10.1080/13880209.2023.2209130. Pharm Biol. 2023. PMID: 37212299 Free PMC article.
-
Neuroprotective Potential of Origanum majorana L. Essential Oil Against Scopolamine-Induced Memory Deficits and Oxidative Stress in a Zebrafish Model.Biomolecules. 2025 Jan 16;15(1):138. doi: 10.3390/biom15010138. Biomolecules. 2025. PMID: 39858532 Free PMC article.
-
Effects of Moringa oleifera in Two Independents Formulation and as Neuroprotective Agent Against Scopolamine-Induced Memory Impairment in Mice.Front Nutr. 2022 Mar 1;9:799127. doi: 10.3389/fnut.2022.799127. eCollection 2022. Front Nutr. 2022. PMID: 35299766 Free PMC article.
-
Neuroprotective Potential of Phytocompounds in the Treatment of Dementia: The State of Knowledge from the Scopolamine-Induced Animal Model of Alzheimer's Disease.Curr Issues Mol Biol. 2025 Aug 8;47(8):635. doi: 10.3390/cimb47080635. Curr Issues Mol Biol. 2025. PMID: 40864789 Free PMC article. Review.
-
Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease.Curr Alzheimer Res. 2024;21(1):50-68. doi: 10.2174/0115672050306008240321034006. Curr Alzheimer Res. 2024. PMID: 38529600 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials